 FARMINGDALE, N.Y., Feb. 11, 2021 GLOBE NEWSWIRE -- Misonix, Inc. NASDAQ: MSON, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be participating in two upcoming investor conferences. 